- Home
- SENS vs KMDA Comparison
SENS vs KMDA Comparison
Compare SENS & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENS
- KMDA
- Stock Information
- Founded
- SENS 1996
- KMDA 1990
- Country
- SENS United States
- KMDA Israel
- Employees
- SENS N/A
- KMDA N/A
- Industry
- SENS Industrial Machinery/Components
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- SENS Industrials
- KMDA Health Care
- Exchange
- SENS Nasdaq
- KMDA Nasdaq
- Market Cap
- SENS 372.6M
- KMDA 430.1M
- IPO Year
- SENS N/A
- KMDA N/A
- Fundamental
- Price
- SENS $0.47
- KMDA $7.13
- Analyst Decision
- SENS Strong Buy
- KMDA Strong Buy
- Analyst Count
- SENS 5
- KMDA 2
- Target Price
- SENS $1.63
- KMDA $13.00
- AVG Volume (30 Days)
- SENS 4.8M
- KMDA 50.1K
- Earning Date
- SENS 08-06-2025
- KMDA 08-13-2025
- Dividend Yield
- SENS N/A
- KMDA 2.81%
- EPS Growth
- SENS N/A
- KMDA 27.97
- EPS
- SENS N/A
- KMDA 0.32
- Revenue
- SENS $25,466,000.00
- KMDA $169,517,000.00
- Revenue This Year
- SENS $63.52
- KMDA $14.49
- Revenue Next Year
- SENS $67.91
- KMDA $10.12
- P/E Ratio
- SENS N/A
- KMDA $21.28
- Revenue Growth
- SENS 5.94
- KMDA 9.67
- 52 Week Low
- SENS $0.25
- KMDA $5.17
- 52 Week High
- SENS $1.40
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- SENS 45.64
- KMDA 45.82
- Support Level
- SENS $0.43
- KMDA $6.97
- Resistance Level
- SENS $0.47
- KMDA $7.28
- Average True Range (ATR)
- SENS 0.02
- KMDA 0.19
- MACD
- SENS 0.00
- KMDA -0.01
- Stochastic Oscillator
- SENS 51.35
- KMDA 22.58
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.